Learn More

Targeted Radioisotope Therapy Webinar Series

The new technologies of radionuclide therapy are allowing for personalized treatment of various forms of cancer. Learn more about the clinical utility of these procedures and earn free CE credit.

Healthcare Provider

Welcome to our Healthcare Provider portal. Everything you need to understand the advantages and applications of nuclear medicine and molecular imaging in your practice. Find out more about ordering the right test for the right patient at the right time.

What are Nuclear Medicine and Molecular Imaging?

Molecular imaging is a type of medical imaging that provides detailed pictures of what is happening inside the body at the molecular and cellular level. Where other diagnostic imaging procedures—such as x-rays, computed tomography (CT) and ultrasound—offer pictures of physical structure, molecular imaging allows physicians to see how the body is functioning and to measure its chemical and biological processes.

Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials (radiopharmaceuticals) to diagnose and treat disease. In nuclear medicine imaging, the radiopharmaceuticals are detected by special types of cameras that work with computers to provide very precise pictures of the area of the body being imaged. Nuclear medicine can also be used to treat certain types of cancer and  other diseases.

Molecular imaging offers unique insights into the human body that enable physicians to personalize patient care. In terms of diagnosis, molecular imaging is able to:

  • provide information that is unattainable with other imaging technologies or that would require more invasive procedures such as biopsy or surgery
  • identify disease in its earliest stages and determine the exact location of a tumor, often before symptoms occur or abnormalities can be detected with other diagnostic tests

Learn More

 

Disease-Specific Information

Oncology

Cancer Scan

Cardiology

Heart Scan

Neurology

Brain Scan

Guidance

SNMMI has created guidelines to identify those elements of the procedure that are most important in obtaining a high-quality examination, Appropriate Use Criteria (AUC), and is working towards optimizing dose.

Guidelines
Appropriate Use Criteria
Dosimetry
Dose Optimization

Related Resources

NCCN's Guidelines Tabular Summary
NCCN Practice Guidelines Narrative Summary

Ordering Information

The SNMMI PET Center of Excellence has created a go-to resource with in-depth ordering information and printable materials related to PET and PET/CT, including:

  • Sample Request Forms
  • Sample Letters of Medical Necessity
  • Sample Reports from Nuclear Medicine Physician
  • CMS Decision Memos

Learn More

Request a Speaker

SNMMI is dedicated to providing the community with access to the most knowledgeable and experienced speakers in the field of nuclear medicine and molecular imaging. As part of the new Outreach Program, SNMMI is working to enhance relationships with relevant societies and patient organizations. We have created a pool of speakers who can speak at your next meeting. Please complete the form below to request a speaker.

Outreach Speaker Request Form
Outreach Program
FAQs

 

 

  • October 21, 2014NANETS / SNMMI Symposium: Improvements in NET Imaging

    SNMMI and the North American Neuroendocrine Tumor Society (NANETS) held their first joint symposium to provide an in-depth review of the clinical utility of the nuclear medicine technologies for NETs.
    (SNMMI News)

  • October 19, 2014Gamblers Get Less Of a Buzz From Pleasure, Study Finds

    New research presented at the European College of Neuropsychopharmacology Congress in Berlin sheds light on what happens in the brains of gamblers.
    (MI: Making a Difference)

  • October 16, 2014Radium-223 Shortage Due to Production Issue

    The prostate cancer drug radium-223 (Xofigo) is temporarily unavailable due to a manufacturing issue. The FDA Drug Shortage website indicates that the drug shortage was first reported October 7.
    (SNMMI News)

  • October 15, 2014Molecular imaging of stroke

    While CT and MR are still the mainstays of detecting ischemic stroke, several SPECT and PET imaging techniques have been developed and are on the way to add comprehensive clinical information in the case of cerebrovascular disease. With this in mind, hybrid imaging such as PET/MR could provide a best-possible map of variables involved in stroke, according to a review published Oct. 9 in the Journal of Nuclear Medicine .
    (MI: Making a Difference)

Featured Resources

  • Guidance

    Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.

  • Legislative Issues

    SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis.

  • Annual Reports

  • Journals

    Learn more about journals published by or sponsored by the Society of Nuclear Medicine and Molecular Imaging.